Cargando…

CHEK2(p.I157T) Mutation Is Associated with Increased Risk of Adult-Type Ovarian Granulosa Cell Tumors

SIMPLE SUMMARY: Granulosa cell tumors of the ovary represent a distinct subset of ovarian cancers typically characterized by hormonal disbalance, slow disease progression, and late recurrence years after surgical removal of the primary tumor. Risk factors associated with development of these rare tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Švajdler, Peter, Vasovčák, Peter, Švajdler, Marián, Šedivcová, Monika, Urbán, Veronika, Michal, Michal, Mezencev, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909001/ https://www.ncbi.nlm.nih.gov/pubmed/35267514 http://dx.doi.org/10.3390/cancers14051208

Ejemplares similares

Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen’s disease
por: Švajdler, Marián, et al.
Publicado: (2016)

Predictive factors of endometriosis progression into ovarian cancer
por: Varga, Ján, et al.
Publicado: (2022)

Hemorrhagic Epidermoid Cyst in Cerebellar Vermis: Case Report and Review of the Literature
por: Kozák, Ján, et al.
Publicado: (2021)

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium
por: Muranen, Taru A., et al.
Publicado: (2016)

Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures
por: Ow, Ghim Siong, et al.
Publicado: (2014)

The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer
por: Banaszkiewicz, Monika, et al.
Publicado: (2012)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007)

The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study
por: Alorjani, Mohammed, et al.
Publicado: (2023)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

CHEK2 mutations in pediatric brain tumors
por: Tlais, Dana, et al.
Publicado: (2023)

Lethal hemorrhagic necrotizing pancreatitis in a child with congenital immunodeficiency and COVID-19
por: Zahradníková, Petra, et al.
Publicado: (2022)

HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients
por: Bucova, Maria, et al.
Publicado: (2022)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou, Panagiotis, et al.
Publicado: (2017)

Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy
por: Banaszkiewicz, Monika, et al.
Publicado: (2013)

Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan
por: Rashid, Muhammad U, et al.
Publicado: (2013)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Clinical relevance of CHEK2 and NBN mutations in the macedonian population
por: Kostovska, I Maleva, et al.
Publicado: (2015)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
por: Koen, Kortbeek, et al.
Publicado: (2022)

Recurrent Acromegaly in a Patient With a CHEK2 Mutation
por: Perosevic, Milica, et al.
Publicado: (2021)

Multiple Primary Melanoma in a CHEK2 Mutation Carrier
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2023)

Mutations in STK11 gene in Czech Peutz-Jeghers patients
por: Vasovčák, Peter, et al.
Publicado: (2009)

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients
por: Suspitsin, Evgeny N, et al.
Publicado: (2009)

A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors
por: Němejcová, Kristýna, et al.
Publicado: (2023)

CHEK2 (∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations
por: Stružinská, Ivana, et al.
Publicado: (2023)

Low Prevalence of CHEK2 Gene Mutations in Multiethnic Cohorts of Breast Cancer Patients in Malaysia
por: Mohamad, Suriati, et al.
Publicado: (2015)

Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening
por: Mezencev, Roman, et al.
Publicado: (2012)

Multiple primary malignancies and subtle mucocutaneous lesions associated with a novel PTEN gene mutation in a patient with Cowden syndrome: Case report
por: Vasovčák, Peter, et al.
Publicado: (2011)

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
por: Massink, Maarten P. G., et al.
Publicado: (2015)

Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports
por: Li, Qiang, et al.
Publicado: (2018)

An association study between CHEK2 gene mutations and susceptibility to breast cancer
por: Jalilvand, Manizheh, et al.
Publicado: (2017)

CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report
por: Szeliga, Anna, et al.
Publicado: (2020)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

Maternal heterozygous mutation in CHEK1 leads to mitotic arrest in human zygotes
por: Chen, Beili, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epe64ve9rdenm42pjr0b7o9h9b